1 year return (CAGR)
-26.86%
Keros Therapeutics Inc Exchange (NASDAQ, USD)
KROS
11.63
-0.10 (-0.85%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-31.08%
5 year return (CAGR)
-17.91%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
230.59M
Price/Sales
6.95
Ent value
-1.74M
Price/Book
0.88
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 11.68 |
| Daily high | 11.82 |
| Daily low | 11.49 |
| Daily Volume | 158K |
| All-time high | 82.74 |
| 1y analyst estimate | 19.83 |
| Beta | 1.01 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 4 Mar 2026 |
Downside potential
Loading...
Downside potential data
| KROS | S&P500 | |
| Current price drop from All-time high | -85.94% | -1.29% |
| Highest price drop | -88.46% | -56.47% |
| Date of highest drop | 1 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -50.17% | -10.68% |
| Avg time to new high | 51 days | 12 days |
| Max time to new high | 1447 days | 1805 days |
News
